Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Xeris Biopharma Holdings Inc (NASDAQ: XERS) closed at $8.31 in the last session, up 3.75% from day before closing price of $8.01. In other words, the price has increased by $3.75 from its previous closing price. On the day, 2.59 million shares were traded. XERS stock price reached its highest trading level at $8.37 during the session, while it also had its lowest trading level at $7.88.
Ratios:
We take a closer look at XERS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.24 and its Current Ratio is at 1.95.
On November 11, 2024, Piper Sandler Downgraded its rating to Neutral which previously was Overweight but kept the price unchanged to $3.
On March 28, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $5.Oppenheimer initiated its Outperform rating on March 28, 2024, with a $5 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 11 ’25 when PERSKY MARLA sold 15,500 shares for $7.72 per share. The transaction valued at 119,610 led to the insider holds 142,000 shares of the business.
MARLA PERSKY bought 15,500 shares of XERS for $121,055 on Sep 11 ’25. On Aug 28 ’25, another insider, SHERMAN JEFFREY W, who serves as the Director of the company, sold 42,232 shares for $7.92 each. As a result, the insider received 334,515 and left with 219,188 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XERS now has a Market Capitalization of 1341901952 and an Enterprise Value of 1539839872. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.45. Its current Enterprise Value per Revenue stands at 6.259 whereas that against EBITDA is 183.73.
Stock Price History:
The Beta on a monthly basis for XERS is 0.50, which has changed by 1.7885907 over the last 52 weeks, in comparison to a change of 0.16766965 over the same period for the S&P500. Over the past 52 weeks, XERS has reached a high of $8.35, while it has fallen to a 52-week low of $2.73. The 50-Day Moving Average of the stock is 15.27%, while the 200-Day Moving Average is calculated to be 64.79%.
Shares Statistics:
According to the various share statistics, XERS traded on average about 2.39M shares per day over the past 3-months and 2302060 shares per day over the past 10 days. A total of 161.22M shares are outstanding, with a floating share count of 151.50M. Insiders hold about 6.18% of the company’s shares, while institutions hold 56.36% stake in the company. Shares short for XERS as of 1757894400 were 16240329 with a Short Ratio of 6.79, compared to 1755216000 on 13346477. Therefore, it implies a Short% of Shares Outstanding of 16240329 and a Short% of Float of 10.459999999999999.
